4//SEC Filing
WAUD REEVE B 4
Accession 0000899243-20-016428
CIK 0001520697other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:50 PM ET
Size
9.7 KB
Accession
0000899243-20-016428
Insider Transaction Report
Form 4
WAUD REEVE B
Director10% Owner
Transactions
- Sale
Common Stock, par value $0.01 per share
2020-06-12$25.88/sh−88,978$2,303,044→ 671,317 total(indirect: See Footnotes) - Sale
Common Stock, par value $0.01 per share
2020-06-12$25.84/sh−33,333$861,378→ 760,295 total(indirect: See Footnotes)
Holdings
- 25,765
Common Stock, par value $0.01 per share
Footnotes (7)
- [F1]Represents shares sold by Melissa W. Waud, Mr. Waud's wife.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $25.32 to $26.51, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Following both of the transactions reported in this Form 4, the shares are owned of record as follows: (i) 266,934 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (iv) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").
- [F4]Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.
- [F5]Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
- [F6]Represents shares sold by the Halcyon Trust.
- [F7]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $25.32 to $26.55, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Acadia Healthcare Company, Inc.
CIK 0001520697
Entity typeother
Related Parties
1- filerCIK 0001421620
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 7:50 PM ET
- Size
- 9.7 KB